
New molecular diagnostic research institute
Siemens Healthcare is working on diagnostic tests for early detection and characterziation of a patient's tumor cells. The Cologne laboratories for molecular diagnostics especially concentrate on the research of breast cancer, a disease that still is number one cause of death among women. The results should help to adapt a customized therapy to the individual patient.















